Informed Prostate Cancer Patient Support

Breakthrough Urine Test Could Transform Early Prostate Cancer Detection Revolutionary non-invasive screening method shows higher accuracy than PSA testing A groundbreaking study recently published in the journal Cancer Research reveals that prostate cancer may soon be detected at earlier stages through a simple urine test. Researchers from Karolinska Institutet (Sweden), Imperial College London (UK), and Xiyuan Hospital (China) have identified new biomarkers with high diagnostic precision using artificial intelligence and extensive analyses of gene activity in tumors. How the New Test Works The innovative approach began with analyzing mRNA activity across thousands of individual cells in prostate tumors. By mapping the position and cancer grade of each cell, researchers constructed detailed digital models of prostate cancer. These models were then analyzed using AI to identify proteins that could serve as reliable biomarkers. The research team tested these biomarkers in nearly 2,...

  The concept of chimeric RNA formation - showing how normal RNA from separate genes (Gene A and Gene B) undergoes splicing mechanisms to create fusion RNA molecules The population-specific patterns discovered in the research - visually representing the different chimeric RNA patterns found in Western men versus Chinese men The clinical implications of this discovery - highlighting the potential for improved diagnostics and targeted therapies Genetic "Chimeras" Could Revolutionize Prostate Cancer Treatment New research reveals how personalized therapies targeting unique RNA signatures may improve outcomes across different populations A groundbreaking discovery by researchers at the University of Virginia Cancer Center could transform how prostate cancer is treated worldwide. Scientists have identified that prostate cancer has distinct genetic properties in different groups of men that can be targeted to develop more precise and effective treatments. Understanding Ch...

04/22/2025 - Hi-Risk/Recurrent/Advanced PCa Men & Caregivers - YouTube

4/23/2025 - Active Surveillance Prostate Cancer - YouTube Active Surveillance Prostate Cancer - 4/23/2025 AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics. Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us. You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ . Sign up to receive a weekly Reminder/Newsletter for th...